A Comparison of Visual Function After Bilateral Implantation of Presbyopia-correcting Intraocular Lenses (IOLs)
Study Details
Study Description
Brief Summary
The purpose of this study is to prospectively evaluate postoperative visual and refractive parameters in a series of subjects bilaterally implanted with the AcrySof® IQ ReSTOR® +3 versus those bilaterally implanted with the Tecnis Multifocal 1-piece.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: ReSTOR +3 Bilateral Implantation of ReSTOR +3 Intraocular lenses after cataract extraction |
Device: ReSTOR +3
Bilateral implantation of ReSTOR +3 Intraocular Lenses (IOLs) after cataract extraction
|
Active Comparator: Tecnis MF Bilateral Implantation of Tecnis Multifocal Intraocular lenses after cataract extraction |
Device: Tecnis MF
Bilateral implantation of Tecnis Multifocal (MF) Intraocular Lenses (IOLs) after cataract extraction
|
Outcome Measures
Primary Outcome Measures
- Defocus Curve [3 months after surgery]
A defocus curve is created by multiple measurements of one's visual acuity at different spherical powers (recorded as Diopters (D)). Visual Acuity (VA) is measured in logMAR. LogMAR is the "logarithm of the minimum angle of resolution".
Eligibility Criteria
Criteria
Inclusion Criteria:
-
diagnosed with bilateral cataracts
-
candidate for presbyopic lens
Exclusion Criteria:
-
1 Diopter (D) preoperative astigmatism by Keratometry (K)readings
-
pre-existing conditions that could skew the results
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | The Eye Center of North Florida | Panama City | Florida | United States | 32405 |
2 | Carolina Eye Care Physicians | Charleston | South Carolina | United States | 29414 |
3 | Whitsett Vision Group | Houston | Texas | United States | 77055 |
Sponsors and Collaborators
- Alcon Research
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- M09-050
Study Results
Participant Flow
Recruitment Details | Bilateral diagnosis of cataracts of subjects >21 years of age |
---|---|
Pre-assignment Detail | During the preoperative exam, subjects were examined to ensure they met the inclusion/exclusion criteria. |
Arm/Group Title | ReSTOR +3 | Tecnis MF |
---|---|---|
Arm/Group Description | Bilateral Implantation of ReSTOR +3 Intraocular lenses after cataract extraction | Bilateral Implantation of Tecnis Multifocal Intraocular lenses after cataract extraction |
Period Title: Overall Study | ||
STARTED | 33 | 31 |
COMPLETED | 32 | 30 |
NOT COMPLETED | 1 | 1 |
Baseline Characteristics
Arm/Group Title | ReSTOR +3 | Tecnis MF | Total |
---|---|---|---|
Arm/Group Description | Bilateral Implantation of ReSTOR +3 Intraocular lenses after cataract extraction | Bilateral Implantation of Tecnis Multifocal Intraocular lenses after cataract extraction | Total of all reporting groups |
Overall Participants | 33 | 31 | 64 |
Age (Count of Participants) | |||
<=18 years |
0
0%
|
0
0%
|
0
0%
|
Between 18 and 65 years |
19
57.6%
|
10
32.3%
|
29
45.3%
|
>=65 years |
14
42.4%
|
21
67.7%
|
35
54.7%
|
Sex: Female, Male (Count of Participants) | |||
Female |
18
54.5%
|
20
64.5%
|
38
59.4%
|
Male |
15
45.5%
|
11
35.5%
|
26
40.6%
|
Outcome Measures
Title | Defocus Curve |
---|---|
Description | A defocus curve is created by multiple measurements of one's visual acuity at different spherical powers (recorded as Diopters (D)). Visual Acuity (VA) is measured in logMAR. LogMAR is the "logarithm of the minimum angle of resolution". |
Time Frame | 3 months after surgery |
Outcome Measure Data
Analysis Population Description |
---|
In the ReSTOR +3 population, 1 subject did not complete the assessment at -5.00 D; therefore, only 32 subjects were used for this measure. |
Arm/Group Title | ReSTOR +3 | Tecnis MF |
---|---|---|
Arm/Group Description | Bilateral Implantation of ReSTOR +3 Intraocular lenses after cataract extraction | Bilateral Implantation of Tecnis Multifocal Intraocular lenses after cataract extraction |
Measure Participants | 33 | 29 |
-5.00 Diopter (D) |
0.585
(0.204)
|
0.653
(0.116)
|
-4.50 D |
0.490
(0.204)
|
0.475
(0.115)
|
-4.00 D |
0.388
(0.189)
|
0.337
(0.107)
|
-3.50 D |
0.261
(0.183)
|
0.168
(0.114)
|
-3.00 D |
0.126
(0.185)
|
0.046
(0.104)
|
-2.50 D |
0.017
(0.144)
|
0.073
(0.113)
|
-2.00 D |
0.055
(0.147)
|
0.222
(0.178)
|
-1.50 D |
0.245
(0.175)
|
0.326
(0.120)
|
-1.00 D |
0.212
(0.144)
|
0.225
(0.128)
|
-0.50 D |
0.052
(0.132)
|
0.072
(0.120)
|
0.00 D |
-0.048
(0.097)
|
-0.044
(0.085)
|
0.50 D |
0.035
(0.112)
|
0.032
(0.111)
|
1.00 D |
0.258
(0.140)
|
0.237
(0.200)
|
1.50 D |
0.434
(0.153)
|
0.364
(0.176)
|
2.00 D |
0.539
(0.168)
|
0.446
(0.136)
|
Adverse Events
Time Frame | Adverse events were collected at all study visits. | |||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | ReSTOR +3 | Tecnis MF | ||
Arm/Group Description | Bilateral Implantation of ReSTOR +3 Intraocular lenses after cataract extraction | Bilateral Implantation of Tecnis Multifocal Intraocular lenses after cataract extraction | ||
All Cause Mortality |
||||
ReSTOR +3 | Tecnis MF | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | / (NaN) | / (NaN) | ||
Serious Adverse Events |
||||
ReSTOR +3 | Tecnis MF | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/32 (0%) | 0/30 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
ReSTOR +3 | Tecnis MF | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/32 (0%) | 0/30 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
The existence of this clinical study is confidential and should not be discussed with persons outside of the study. You shall hold confidential, and not disclose directly or indirectly to any third party other than those persons involved in the study who have a need to know, the protocol, the data arising out of the study, and any other information related to the study or to Alcon's products or research programs that is provided by Alcon to you (the "Confidential Information").
Results Point of Contact
Name/Title | Director of Alcon Clinical |
---|---|
Organization | Alcon Research, Ltd. |
Phone | 888.451.3937; 817.568.6725 |
medinfo@alconlabs.com |
- M09-050